Introduction
Diabetes is considered as the health crisis of the 21 st century. Approximately 15% of all patients with diabetes develop diabetic ulcers. Due to the associated diabetic neuropathy these ulcers are left unattended and are often followed by amputations in the later stages. Due to the increased glucose levels in the tissues, these diabetic ulcers are mostly infected. In recent years the technology of dressing has developed significantly, and several new products which reflect greater knowledge of tissue repair physiology have been produced and successfully used for the management of various types of chronic ulcers. However there is limited information to guide treatment of diabetic ulcers. 1 Growth factors play a very important part in the process of wound healing. Epidermal Growth Factor was discovered by an American Biochemist Stanley Cohen in 1986, for which he won Nobel Prize in physiology and medicine . 2 Epidermal growth factor is a type of growth factor which is synthesized by the cells of the hematopoietic system namely the megakaryocytes, macrophages monocytes and keratinocytes as shown by Loot, Kenter et al. 2002 . It act by regulating the proliferation, migration and differentiation of cells by a mechanism of binding to receptor kinases on target cells  EGF is one of the key signaling molecules in stimulating epithelial cell motility, making it a required factor for re-epithelialization  EGF is a major stimulator of fibroblast migration and wound contraction Studies have proved that EGF is more useful in acute than in chronic wounds as this factor is readily degraded in the chronic wound milieu. There are limited studies in Indian subcontinent and no major studies in south Indian population conducted so far. This study is intended to show the efficacy of epidermal growth factor over conventional dressings in the healing of diabetic ulcers.
II.Aims And Objectives Of The Study
The aim of the present study was to study the efficacy of epidermal growth factor over conventional dressings in the healing of diabetic ulcers.
III. Materials And Methods
The study was a prospective case control comparative Study conducted in the Department of General Surgery, K. S Hegde Hospital during the time period August 2014 to August 2016. The study was done on 40 patients  20 patients with epidermal growth factor dressings  20 patients with conventional wound dressings
The dressing method was decided by the patient after explaining everything about both the dressings.
Inclusion Criteria
• Patients aged 20-80 years of age.
• Patients with diabetes whose blood sugar level are controlled by oral hypoglycaemic drugs or insulin.
• Ulcer size 3-10 cm
Exclusion Criteria
• Patients with any active systemic infections.
• Ulcer size more than 10cm.
• Immuno compromised individuals.
• Any chronic pathology or systemic therapy which would obstruct the healing process.
• Patients with ≥ Grade III Wagner classification of diabetic ulcer Procedure Any dressings from the wound was removed and discarded. Wound irrigation was done with normal saline. Surgical debridement was done and adequate hemostasis achieved, following which  20 patients received topical Epidermal growth factor dressing.  20 patients received conventional wound dressing
The size of the ulcer measured in day 1, day15 and one month
IV.Results And Observations
Gender distribution Males predominated in our study. However between the two groups there was no statistical difference in the gender 
V. Discussion
Based on the analysis of the results and comparing with other similar studies, following inferences can be drawn:  We found that in our study the size of the ulcer significantly decreased with EGF  It was noticed that the decrease in ulcer size was more evident in the first 15 days when compared to the next 15 days.  During this time the ulcer size has reduced more than 50% as compared to the conventional group in which the decrease in size was less than 25 % for most ulcers  In our study we also noted that as compared to the first day, on the 30 th day the ulcer healing in terms of size ranged from 54-81.5% in the EGF group as compared to the conventional group in which the decrease in size ranged from 34-47%  In our study we also found that the patient satisfaction and co-operation was much better in the EGF group as compared to the conventional group in most ulcers. The possible reason attributed to this is the lesser need of surgical debridement due to lesser slough.  The amount of pain experienced was lesser in the study group as compared to the conventional group in most ulcers  The therapeutic achievements of EGF are by EGF receptor stimulation and cyto-protection and proliferation effects. 
VI. Conclusion
In our study we have concluded that Epidermal Growth Factor definitely has an edge over conventional dressings in the healing of diabetic ulcers in terms of granulation tissue formation, and healing of the ulcer especially in diabetic wounds of duration less than a month
Limitations
The limitations of the study are • As ours is a tertiary care centre, the cases don't represent the actual burden and type in the population at study • The small sample size in comparison to the disease burden in the society • The short duration of study as compared to the chronicity of the disease
